Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leader in fertility benefits management, announced its CEO, Pete Anevski, will present at the 40th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny, Inc. (Nasdaq: PGNY), a leader in fertility benefits management, announced its CEO, Pete Anevski, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 8:15 A.M. ET. The presentation will be followed by a breakout session featuring President Michael Sturmer and CFO Mark Livingston. A live audiocast and replay will be accessible on Progyny's website. Progyny is recognized for its innovative fertility solutions that benefit patients, employers, and healthcare providers alike.
Details
News Market Reaction – PGNY
The recorded move for PGNY in the trading session of this news was -4.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 A.M. Eastern Time. Following the presentation, Michael Sturmer, Progyny’s President, and Mark Livingston, Progyny’s Chief Financial Officer, will join Mr. Anevski for a breakout session.
A live audiocast and replay of both the presentation and the breakout session will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.